Search results
Why Medicare Advantage Plans Are Likely To Be Squeezed Next Year, Reduce Benefits
Forbes· 4 days agoMedicare Advantage plans are popular. There could be significant modifications to existing Advantage...
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
San Jose Mercury News· 7 days agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients,...
Opinion: Silent crisis in rural America is Medicare's diminishing value post Inflation Reduction Act
Tulsa World· 1 day agoFor decades, Medicare has served as a crucial pillar of health care for America's seniors,...
Ask Kevin: What’s the best Medicare Advantage plan for Arizona resident?
Federal Times· 4 days agoThe following is a question submitted by a Federal Times reader to columnist Kevin Moss, a senior editor at Consumers’ Checkbook and expert on federal employee health insurance plans for civil ...
Original Medicare vs. Medicare Advantage: Which Should You Trust Your Health To?
Investopedia· 1 day agoIf you already have Medicare Parts A and B (or soon will), you can choose to receive your Medicare...
Amazon Pharmacy Targets Medicare Population
Forbes· 3 days agoMillions of seniors who are 65 and older tend to have drug coverage if they purchase privatized health insurance known as Medicare Advantage or a...
Is the Inflation Reduction Act failing Oklahoma’s senior citizens? | Opinion
The Oklahoman· 2 days agoBiden, but the mega-billion spending boondoggle known as the Inflation Reduction Act (IRA) genuinely...
Ask Kevin: Due to income, Medicare payment is high. Should I keep it?
Federal Times· 7 days agoMy husband is 80 and is also covered under my FEHB insurance. Due to our income, our Medicare payments will be very high: more than $12,000 per year for the two of us. Is ...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 4 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development ...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 4 days agoAshkenazi, who will step in as the new CFO of Alphabet on July 31, has been key to managing the...